chr7-44114813-T-TCATC
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_006230.4(POLD2):c.1378_1381dupGATG(p.Asp461GlyfsTer2) variant causes a frameshift, stop gained change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Consequence
POLD2
NM_006230.4 frameshift, stop_gained
NM_006230.4 frameshift, stop_gained
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.48
Publications
0 publications found
Genes affected
POLD2 (HGNC:9176): (DNA polymerase delta 2, accessory subunit) This gene encodes the 50-kDa catalytic subunit of DNA polymerase delta. DNA polymerase delta possesses both polymerase and 3' to 5' exonuclease activity and plays a critical role in DNA replication and repair. The encoded protein is required for the stimulation of DNA polymerase delta activity by the processivity cofactor proliferating cell nuclear antigen (PCNA). Expression of this gene may be a marker for ovarian carcinomas. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 5. [provided by RefSeq, Mar 2012]
AEBP1 (HGNC:303): (AE binding protein 1) This gene encodes a member of carboxypeptidase A protein family. The encoded protein may function as a transcriptional repressor and play a role in adipogenesis and smooth muscle cell differentiation. Studies in mice suggest that this gene functions in wound healing and abdominal wall development. Overexpression of this gene is associated with glioblastoma. [provided by RefSeq, May 2013]
AEBP1 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndrome, classic-like, 2Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006230.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| POLD2 | MANE Select | c.1378_1381dupGATG | p.Asp461GlyfsTer2 | frameshift stop_gained | Exon 11 of 11 | NP_006221.3 | P49005 | ||
| POLD2 | c.1378_1381dupGATG | p.Asp461GlyfsTer2 | frameshift stop_gained | Exon 11 of 11 | NP_001120690.1 | P49005 | |||
| POLD2 | c.1378_1381dupGATG | p.Asp461GlyfsTer2 | frameshift stop_gained | Exon 12 of 12 | NP_001243808.1 | P49005 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| POLD2 | TSL:1 MANE Select | c.1378_1381dupGATG | p.Asp461GlyfsTer2 | frameshift stop_gained | Exon 11 of 11 | ENSP00000480186.2 | P49005 | ||
| POLD2 | TSL:1 | c.1378_1381dupGATG | p.Asp461GlyfsTer2 | frameshift stop_gained | Exon 11 of 11 | ENSP00000395231.1 | P49005 | ||
| POLD2 | c.1405_1408dupGATG | p.Asp470GlyfsTer2 | frameshift stop_gained | Exon 11 of 11 | ENSP00000551368.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
ClinVar submissions
View on ClinVar Significance:Uncertain significance
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
1
-
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.